세계의 헤르페스 마커 검사 시장 : 적응증별, 검사 유형별, 용도별 - 예측(2025-2030년)

The Herpes Marker Testing Market was valued at USD 468.22 million in 2023, expected to reach USD 497.86 million in 2024, and is projected to grow at a CAGR of 6.46%, to USD 725.83 million by 2030.

Herpes marker testing is a crucial segment within the broader diagnostic testing market, focused on identifying and managing herpes simplex virus (HSV) infections through clinical assays that detect viral antigens or antibodies in biological samples. The necessity for herpes marker testing is driven by the high prevalence of HSV infections globally, the need for timely and accurate diagnosis for effective disease management, and the rising demand for personalized medicine. Applications range from routine diagnostic practices in healthcare facilities to research explorations aimed at understanding the virus's epidemiology and developing vaccines. End-users primarily include hospitals, diagnostic laboratories, and research institutions. Market growth is influenced by factors like advancements in molecular testing technologies, increasing awareness about sexually transmitted infections (STIs), and rising healthcare expenditure. However, challenges to growth include the high costs of advanced diagnostic systems, limited availability of point-of-care testing in low-resource regions, and social stigma associated with STIs hindering individuals from seeking diagnosis. Emerging opportunities lie in the expansion of testing services in developing regions with improving healthcare infrastructure and the ongoing R&D efforts to enhance test precision and reduce time-to-result. Companies can capitalize on the growing trend towards home-based testing kits and digital health platforms for remote diagnosis. However, regulatory scrutiny and the need for high specificity and sensitivity in test results remain critical barriers. Innovation in this space could focus on developing cost-effective, rapid-result test kits suitable for home use and integrating artificial intelligence for predictive diagnosis and personalized treatment plans. The market is dynamic with moderate to high competition, requiring strategic partnerships and continuous innovation for sustained growth. Overall, targeted investment in R&D, coupled with strategic market expansion strategies, will be key to capitalizing on future growth opportunities while navigating existing challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Herpes Marker Testing Market

The Herpes Marker Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of herpes infections among population
  • Growing awareness of early diagnosis and treatments of oral and genital infection
  • Rising healthcare spendings and improved healthcare infrastructure
• Market Restraints
  • Limited availability of laboratories along with lack of skilled personnel
• Market Opportunities
  • Introduction of newly developed herpes testing kits
  • Growing research activities for novel vaccines to treat herpes infections
• Market Challenges
  • Stringent and time consuming approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Herpes Marker Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Herpes Marker Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Herpes Marker Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Herpes Marker Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Herpes Marker Testing Market

A detailed market share analysis in the Herpes Marker Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Herpes Marker Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Herpes Marker Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Herpes Marker Testing Market

A strategic analysis of the Herpes Marker Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Herpes Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, AdvaCare Pharma, Bio-Diagnostics Ltd., Bio-Rad Laboratories, Inc., bioMerieux SA, Biopanda Reagents Ltd., CTK Biotech, Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Genome Diagnostics Pvt. Ltd., Hologic, Inc., InTec PRODUCTS, INC., Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor, Inc., Norgen Biotek Corporation, QED Bioscience, Inc., Qiagen N.V., Quidel Corporation, Rapid STD Testing by RSC Health, PA, Teco Diagnostics, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Herpes Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Indication, market is studied across HSV-1 and HSV-2.
• Based on Test Type, market is studied across Antibody or Antigen-based Kits, Nucleic Acid Amplification based Kits, and Viral Culture Test.
• Based on Application, market is studied across Clinical and Research.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of herpes infections among population
    • 5.1.1.2. Growing awareness of early diagnosis and treatments of oral and genital infection
    • 5.1.1.3. Rising healthcare spendings and improved healthcare infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of laboratories along with lack of skilled personnel
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of newly developed herpes testing kits
    • 5.1.3.2. Growing research activities for novel vaccines to treat herpes infections
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent and time consuming approval processes
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Herpes Marker Testing Market, by Indication

• 6.1. Introduction
• 6.2. HSV-1
• 6.3. HSV-2

7. Herpes Marker Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Antibody or Antigen-based Kits
• 7.3. Nucleic Acid Amplification based Kits
• 7.4. Viral Culture Test

8. Herpes Marker Testing Market, by Application

• 8.1. Introduction
• 8.2. Clinical
• 8.3. Research

9. Americas Herpes Marker Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Herpes Marker Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Herpes Marker Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abcam PLC
• 3. AdvaCare Pharma
• 4. Bio-Diagnostics Ltd.
• 5. Bio-Rad Laboratories, Inc.
• 6. bioMerieux SA
• 7. Biopanda Reagents Ltd.
• 8. CTK Biotech, Inc.
• 9. DiaSorin S.p.A.
• 10. F. Hoffmann-La Roche Ltd.
• 11. Genome Diagnostics Pvt. Ltd.
• 12. Hologic, Inc.
• 13. InTec PRODUCTS, INC.
• 14. Merck KGaA
• 15. Meridian Bioscience, Inc. by SD Biosensor, Inc.
• 16. Norgen Biotek Corporation
• 17. QED Bioscience, Inc.
• 18. Qiagen N.V.
• 19. Quidel Corporation
• 20. Rapid STD Testing by RSC Health, PA
• 21. Teco Diagnostics
• 22. Thermo Fisher Scientific, Inc.